PerkinElmer

Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic company established in 2019 and headquartered in Suzhou, China, with a research and development office in Singapore. The company specializes in developing advanced diagnostic technologies aimed at infectious diseases, cancer, and chronic diseases. Its offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Through these technologies, Virtue Diagnostics aims to enhance disease detection and management, contributing to improved healthcare outcomes.

BioLegend is a biotechnology company that specializes in the production and manufacture of biomedical and immunological research reagents. Headquartered in Tokyo, Japan, the company focuses on developing a wide range of antibodies and reagents used in various research applications, including flow cytometry, cell biology, and functional studies. Its products support research in critical fields such as immunology, cancer, and stem cell development. By providing high-quality tools for scientists, BioLegend aims to facilitate advancements in research and discovery across multiple scientific disciplines.

Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery of new drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing. The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector. The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.

IDS is a global medical diagnostics business dedicated to the development and provision of innovative automated and manual assays. Our development focus is in the clinical areas of bone and calcium metabolism, growth, hypertension and chronic kidney disease. Our IDS-iSYS system is designed with the flexibility to accommodate unique and challenging requirements, the IDS-iSYS automation brings testing efficiency and uncompromised quality to specialty immunoassay testing. IDS provides a compact bench top system that fully automates immunoassay testing.

Nexcelom Bioscience LLC is a biotechnology company specializing in the development and marketing of image cytometry products for cell analysis in life science and biomedical research. Established in 2003 and based in Lawrence, Massachusetts, the company provides a range of products including the Cellometer, which assists in counting and analyzing cell lines and primary cells using bright field and fluorescence imaging, and the Celigo, a high-throughput image cytometry system designed for both adherent and suspension cells in microwell plates. Nexcelom also offers fluorescent reagents and kits for cell counting and cell-based assays. Its products cater to various research fields, including immuno-oncology, cell therapy, drug discovery, vaccine development, and therapeutic cell line generation, serving the broader life science industry.

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Carterra, Inc. specializes in developing and commercializing innovative biomolecular interaction analysis solutions, primarily utilizing label-free technologies. The company offers a range of products, including its MultipleX 96 array-based surface plasmon resonance (SPR) imaging system and the Continuous Flow Microspotter (CFM), which is designed for high-throughput microarray printing. Carterra's services encompass epitope binning and mapping, first-pass kinetics, and assay development, catering to the needs of pharmaceutical and biotechnology clients. Its advanced platforms enable users to conduct kinetic and epitope analysis, supporting the rapid screening of antibodies and identification of potential therapeutic candidates. Founded in 2005 and headquartered in Salt Lake City, Utah, Carterra has additional offices in California, Massachusetts, and Germany, and distributes its products globally, including in China and Japan.

Horizon Discovery Group PLC is a UK life science company that uses gene editing and gene modulation platforms to produce cells, applying them in research and clinical applications that advance human health. The Company’s gene editing and gene modulation platform, are able to alter almost any DNA sequence or RNA transcription, has generated a catalogue of over 1,000,000 cell and reagent products that help researchers recapitulate the genetic and protein anomalies found in diseases like cancer. These models have been adopted by c12, 000 organizations to better understand of the predictors and drivers of disease and drug response, and by Horizon in a range of services offered to customers, as well as in the Company’s own research R&D pipeline.

Cisbio Bioassays, a life sciences company, develops various assays and reagents for pharmaceutical, biotechnology, academia, and contract research organizations worldwide. It offers G-protein coupled receptor (GPCR), a homogeneous time-resolved fluorescence (HTRF) cellular platform solution; kinases and cell signaling solutions, such as assays for covering various needs for monitoring kinase targets; and a line of HTRF epigenetic toolbox reagents and kits for high throughput screening and investigation of epigenetic targets.

SSI is one of the manufacturers of analytical instruments in China. SSI delivers analytical solutions and services to a wide range of research, academic, government, pharmaceutical, industrial, life sciences and chemical analysis laboratories. Its portfolio includes photoelectric colorimeters, UV-Vis spectrophotometers, atomic absorption spectrophotometers and accessories.

RHS Limited is a biotechnology company based in Thebarton, Australia, that specializes in developing and marketing genetic screening solutions. Founded in 1980, the company offers a range of products, including EmbryoCellect, a preimplantation genetic screening solution, and DOPlify, a whole genome amplification kit. Additionally, RHS provides PG-Seq, a next-generation sequencing workflow for preimplantation genetic testing, as well as related services in preimplantation genetic screening and whole genome amplification. The company focuses on leveraging single-cell genomics technology to detect chromosomal abnormalities in fetal DNA, thereby assisting medical professionals in improving health outcomes through genetic testing. In June 2017, RHS Limited changed its name from Reproductive Health Science Limited and has operated as a subsidiary of PerkinElmer, Inc. since June 2018.

EUROIMMUN AG develops and manufactures medical laboratory reagents for the diagnosis of autoimmune and infectious diseases and allergies. It offers indications for autoimmunity, infections, allergology, antigen detection, and molecular diagnostics; autoimmunity products for rheumatology, hepatology, gastroenterology, endocrinology, neurology, nephrology, dermatology, and infertility; and infection products for immunity determination, CSF diagnostics, emerging viruses, avidity, BIOCHIP Mosaics for infectious serology, and others, as well as additional reagents for determination of acute infections.

Tulip Diagnostics is a domestic providers of in-vitro diagnostic reagents, kits and instruments.

Vanadis Diagnostics, AB develops a solution for non-invasive prenatal testing (NIPT) based on digital analysis of cell-free DNA. The company develops Vanadis Smart NIPT, a non-invasive prenatal testing platform to simplify screening for trisomies 21, 18, and 13 by eliminating the need for complex DNA amplification and analysis. It enables pregnant women to receive reliable and accurate cell-free DNA based screenings through a method for healthcare providers. The company is based in Sollentuna, Sweden. Vanadis Diagnostics, AB operates as a subsidiary of Perten Instruments AB.

The company was founded in 1962 by Mr. Harald Perten. We are experts in quality control of Grain, Flour, Food and Feed, and offer a wide range of analytical equipment for these industries. We are very active in industry associations such as ICC and AACC. Perten Instruments invented the Falling Number method and the Glutomatic method, and continues to invest heavily in R&D. We have worked with NIR since the beginning of the 1980s and offer the most advanced, modern NIR instruments today. The acquisition of Newport Scientific in 2007 expanded our product range to cover instruments for rheological testing and dough characterization. In December 2014 Perten was acquired by PerkinElmer Inc and we are now a PerkinElmer company. Our presence is worldwide through Perten and PerkinElmer offices and distributors, and in total we are active in over 100 countries. The Perten Instruments Group headquarters are located in Stockholm, Sweden, and we have local offices in the USA, China, Germany, France, Italy, Australia, Spain, Turkey and Thailand.

Ceiba Solutions develops informatics platforms and offers managed services to life sciences and health care industries.

Haoyuan, a supplier of molecular infectious disease screening technologies for blood bank and clinical laboratory settings throughout China, extends PerkinElmer's portfolio by adding four infectious disease assays that are approved by China's State Food and Drug Administration (SFDA).

Caliper Life Sciences, Inc. specializes in developing and selling products and services tailored for pharmaceutical and biotechnology companies, as well as not-for-profit research institutions globally. The company provides integrated systems comprising instruments, software, reagents, and laboratory automation tools designed to enhance the drug discovery and development process. Its extensive product offerings include molecular imaging systems, microfluidics, and automation technologies, which address various challenges faced by researchers. Key products involve imaging systems for analyzing cancer and infectious diseases, transgenic animal models for studying gene expression and disease progression, and automated workstations for genomics and proteomics. Additionally, Caliper Life Sciences offers contract research, drug discovery services, and validation support. The company's products are distributed through a direct sales force and a network of distributors, and it is headquartered in Hopkinton, Massachusetts.

Dexela develops a 3-D breast imaging technology for the early detection of breast cancer. It offers DexTop Digital Mammography Workstation, a screening workstation that ensures screening workflow and performance; and Dexela 3D reconstruction engine that is offered to OEM partners as a software module with licensing terms. The company provides flat panel CMOS X-ray detectors that are used in various medical applications, including mammography and tomosynthesis, breast CT, dental CBCT, fluoroscopy, cardiology and angiographic imaging, and bone densitometry, as well as in scientific instrumentation and non-destructive testing applications. It also offers consulting services in the areas of digital tomosynthesis, mammography acquisition geometry, and optimal reconstruction of 3D data; and design and implementation resources for hardware and software engineering projects. Dexela Limited was incorporated in 2003 and is based in London, the United Kingdom. It has an X-ray research and development facility in Sudbury, Massachusetts.

Labtronics Inc is a leading provider of data integration solutions tailored for laboratories across various industries. The company specializes in procedures-based Electronic Laboratory Notebook (ELN) services, notably through its Nexxis ELNTM, designed for quality control applications. In addition to ELN services, Labtronics offers the Nexxis iLABTM laboratory automation platform, which enhances workflow efficiency and instrument integration. By focusing on innovative solutions that address the specific needs of laboratories, Labtronics aims to streamline laboratory processes and improve data management for its clients.

Geospiza Inc. specializes in developing software systems tailored for workflow management in genetic analysis. The company offers two primary products: GeneSifter Analysis Edition, a cloud-based data analysis tool for microarray and sequencing data, and GeneSifter Lab Edition, which supports various laboratory workflows. Geospiza serves a diverse clientele that includes biotechnology and pharmaceutical companies, universities, researchers, contract core facilities, and diagnostic laboratories engaged in genetic testing and the production of biotherapeutics. Founded in 1997 and headquartered in Seattle, Washington, Geospiza focuses on enhancing the efficiency and effectiveness of genetic research and testing processes.

CambridgeSoft Corporation specializes in providing software and solutions for the pharmaceutical, biotechnology, and chemical industries. The company develops a range of products, including enterprise solutions, desktop software, scientific databases, and consulting services, aimed at enhancing discovery, collaboration, and knowledge management. Its principal offering, Chem & Bio Office, is widely recognized as a key communication tool for chemists, facilitating the creation and analysis of chemical and biological information. Additionally, the enterprise version, Chem & Bio Office Enterprise, supports research organizations in deploying comprehensive information solutions through various technologies. CambridgeSoft's offerings are utilized not only in industry but also in higher education and government research, making it a significant player in scientific software development.

ArtusLabs is developing and deploying Web 2.0 enabled software platforms that enable groups of scientists, and thereby individual scientists, to deliver significantly better (and more) business value to their shareholders, faster. ArtusLabs was founded by the same proven team that formed Synthematix, the award winning organization that pioneered the Enterprise Electronic Lab Notebook marketplace. This leadership and development team has extensive expertise in processing, mining and managing complex scientific data and information generated from research activities. With a wealth of experience and very close relationships with scientists around the globe, the team at ArtusLabs continues to build the best collaborative customer experience and technologies for researchers -- hands down.

chemagen is a key player in the field of automated nucleic acid isolation. The purification of DNA, RNA, or viral DNA/RNA is facilitated through chemagen’s proprietary M-PVA Magnetic Bead technology.

VisEn Medical, Inc. specializes in the design, development, and commercialization of fluorescence in vivo imaging technology platforms. The company focuses on its Fluorescence Molecular Tomographic (FMT) imaging systems and various vivo imaging agents that enhance the identification, characterization, and quantification of disease biomarkers and therapeutic efficacy in living organisms. Among its notable products are ReninSense680, an imaging agent used for monitoring hypertension and renal disease biomarkers, and VivoTagR 680 XL, a fluorescent dye suitable for labeling biomolecules in diverse in vitro and in vivo imaging applications. Additionally, VisEn Medical provides advanced fluorescence tomographic imaging systems to support its imaging technology offerings.

A Spokane, Wash.-based provider of molecular cytogenetic diagnostic services.

Surendra Genetic Labs, Pvt. Ltd. provides testing services for pregnant mothers and newborns. The company operates as laboratory, which focuses on fetal, maternal, and newborn health.

SYM-BIO Lifescience, a leading provider of diagnostics instruments and related reagents.

Analytica of Branford, Inc. develops and markets electrospray ion sources for mass spectrometry.

Opto Technology Inc. specializes in the design, development, and manufacturing of optoelectronic products and light-emitting diodes (LEDs). The company produces a variety of LED-related products tailored for diverse applications, including analytical instrumentation, medical and dental lighting, transportation, as well as industrial and architectural uses. Through its innovative solutions, Opto Technology aims to meet the specific needs of various industries by leveraging advanced optoelectronic technology.

rnel Inc., a recognized leader in custom engineered solutions for gas chromatography applications in the petrochemical, food and beverage, and industrial hygiene markets. The acquisitionis an important strategic initiative to expand PerkinElmer's chromatography portfolio and strengthen its application-focused expertise to best serve the biofuels and hydrocarbon processing industries.

LabMetrix Technologies, Inc. provides metrology-based multi-vendor analytical instrument qualification solutions.

Pediatrix's screening reference laboratory and its StepOne® newborn screening product, which is capable of analyzing more than 50 inherited disorders in newborns, to its genetic screening product offerings. The laboratory provides neonatal screening and consultative services to five states and the District of Columbia, as well as to hospitals and medical groups.

ViaCell is a biotechnology company focused on the area of women’s health. The company develops ViaCord, which enables families preserve their baby’s umbilical cord blood at the time of birth for possible future medical use; and ViaCyte, to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs. ViaCell is based in Boston, Massachusetts.

Applied Biosystems is a global leader in providing innovative instruments and reagents to accelerate academic and clinical research, drug discovery and development, pathogen detection, environmental analysis and forensic DNA analysis.